Status:
APPROVED_FOR_MARKETING
Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Brief Summary
This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
December 1 2004
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00097799
Start Date
December 1 2004
Last Update
November 30 2016
Active Locations (115)
Enter a location and click search to find clinical trials sorted by distance.
1
1182.70.127 Health Services Center, Inc.
Anniston, Alabama, United States
2
1182.70.006 Spectrum Medical Group
Phoenix, Arizona, United States
3
1182.70.016 Health for Life Clinic
Little Rock, Arkansas, United States
4
1182.70.065
Anaheim, California, United States